Quarterly report pursuant to Section 13 or 15(d)

SUPPLEMENTAL CASH FLOW INFORMATION

v3.23.3
SUPPLEMENTAL CASH FLOW INFORMATION
9 Months Ended
Sep. 30, 2023
Supplemental Cash Flow Elements [Abstract]  
SUPPLEMENTAL CASH FLOW INFORMATION

15. SUPPLEMENTAL CASH FLOW INFORMATION

 

Supplemental Disclosures of Non Cash Activities

(in thousands)

 

    Nine Months Ended  
    September 30,  
    2023     2022  
             
Taxes accrued for repurchase of restricted shares   $ 21     $ 66  
Purchase of property and equipment included in accounts payable     74       108  
Transaction costs from the sale of Pharma Solutions included in accounts payable     -       137